Biovet JSC (LTS:0III) Ending Cash Position: лв2.03 Mil (As of Dec. 2016)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Biovet JSC Ending Cash Position?

Biovet JSC LTS:0III Ending Cash Position is лв2.03 Mil as of Dec. 2016. The stock has 1 warning sign investors should review.

Biovet JSC's Ending Cash Position for the quarter that ended in Dec. 2016 was лв2.03 Mil.

Biovet JSC's quarterly Ending Cash Position increased from Jun. 2016 (лв6.25 Mil) to Sep. 2016 (лв7.19 Mil) but then declined from Sep. 2016 (лв7.19 Mil) to Dec. 2016 (лв2.03 Mil).

Biovet JSC's annual Ending Cash Position increased from Dec. 2014 (лв2.90 Mil) to Dec. 2015 (лв4.64 Mil) but then declined from Dec. 2015 (лв4.64 Mil) to Dec. 2016 (лв2.03 Mil).

Biovet JSC Ending Cash Position Related Terms

Biovet JSC Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Biovet JSC's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovet JSC Ending Cash Position Chart

Biovet JSC Annual Data
Trend Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Ending Cash Position
Get a 7-Day Free Trial 1.65 3.15 2.90 4.64 2.03

Biovet JSC Quarterly Data
Dec09 Dec10 Dec11 Dec12 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.64 7.24 6.25 7.19 2.03

Biovet JSC Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biovet JSC's Ending Cash Position for the fiscal year that ended in Dec. 2016 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=4.643+-2.615
=2.03

Biovet JSC's Ending Cash Position for the quarter that ended in Dec. 2016 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=4.943+-2.915
=2.03

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of лв2.03 Mil mean?
Biovet JSC (LTS:0III) has a Ending Cash Position of лв2.03 Mil as of Dec. 2016. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Biovet JSC and its competitors.
Is Biovet JSC's Ending Cash Position too high?
Biovet JSC's current Ending Cash Position is лв2.03 Mil.
How does Biovet JSC's Ending Cash Position compare to ADMP and AGRX?
Biovet JSC's Ending Cash Position of лв2.03 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Drug Manufacturers company?
A good Ending Cash Position depends on the Drug Manufacturers industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Biovet JSC and its competitors. Biovet JSC's current Ending Cash Position is лв2.03 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biovet JSC stock overvalued right now?
Biovet JSC (LTS:0III) has a current Ending Cash Position of лв2.03 Mil. The current Ending Cash Position is лв2.03 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Biovet JSC (LTS:0III), the current Ending Cash Position is лв2.03 Mil as of Dec. 2016. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biovet JSC Business Description

Biovet JSC manufactures & markets medicated and nutritional feed additives, enzymes, bulk active substances & pharmaceuticals for animal productivity & health. It offers intermediates, active ingredients and medicines for human pharmaceutical industry.